GPT and metabolic dysfunction-associated steatotic liver disease: In a previous study, AAP administration reduced the levels of plasma AST, ALT, LDL-C, and TC and increased HDL-C in NAFLD mice, indicating that liver injury and abnormal lipid metabolism were improved due to the AAP intervention.